Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation

BACKGROUND: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is widely used as a curative treatment strategy for most types of hematological diseases. However, strategies for enhancing the graft versus leukemia (GVL) effect without aggravating the graft versus host disease (GVHD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Zhang, Ming, Li, Mengqi, Li, Yingchun, Yang, Wei, Liu, Zhuogang, Wang, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509542/
https://www.ncbi.nlm.nih.gov/pubmed/36153563
http://dx.doi.org/10.1186/s13287-022-03170-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509542/
https://www.ncbi.nlm.nih.gov/pubmed/36153563
http://dx.doi.org/10.1186/s13287-022-03170-x

Ejemplares similares